Cargando…
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495635/ https://www.ncbi.nlm.nih.gov/pubmed/36168458 http://dx.doi.org/10.1017/ash.2021.166 |
| _version_ | 1784794067341672448 |
|---|---|
| author | Smith, Hayden L. Prescher, Maura J. Sittig, Katherine R. Veach, Lisa A. |
| author_facet | Smith, Hayden L. Prescher, Maura J. Sittig, Katherine R. Veach, Lisa A. |
| author_sort | Smith, Hayden L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9495635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Cambridge University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94956352022-09-26 Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest Smith, Hayden L. Prescher, Maura J. Sittig, Katherine R. Veach, Lisa A. Antimicrob Steward Healthc Epidemiol Research Brief Cambridge University Press 2021-07-23 /pmc/articles/PMC9495635/ /pubmed/36168458 http://dx.doi.org/10.1017/ash.2021.166 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Research Brief Smith, Hayden L. Prescher, Maura J. Sittig, Katherine R. Veach, Lisa A. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest |
| title | Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest |
| title_full | Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest |
| title_fullStr | Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest |
| title_full_unstemmed | Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest |
| title_short | Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest |
| title_sort | severe acute respiratory coronavirus virus 2 (sars-cov-2) vaccine acceptance in employees in an integrated health system in the midwest |
| topic | Research Brief |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495635/ https://www.ncbi.nlm.nih.gov/pubmed/36168458 http://dx.doi.org/10.1017/ash.2021.166 |
| work_keys_str_mv | AT smithhaydenl severeacuterespiratorycoronavirusvirus2sarscov2vaccineacceptanceinemployeesinanintegratedhealthsysteminthemidwest AT preschermauraj severeacuterespiratorycoronavirusvirus2sarscov2vaccineacceptanceinemployeesinanintegratedhealthsysteminthemidwest AT sittigkatheriner severeacuterespiratorycoronavirusvirus2sarscov2vaccineacceptanceinemployeesinanintegratedhealthsysteminthemidwest AT veachlisaa severeacuterespiratorycoronavirusvirus2sarscov2vaccineacceptanceinemployeesinanintegratedhealthsysteminthemidwest |